Sanofi (SNYNF) Profit After Tax Growth (5y) (2014 - 2026)

Sanofi (SNYNF) Profit After Tax Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Sanofi	-	-	9.49 Bn

Historic Data

Download Data

Date	Value
Mar 31, 2026	-0.07%
Dec 31, 2025	-51.63%
Sep 30, 2025	34.59%
Jun 30, 2025	-11.83%
Mar 31, 2025	1.25%
Dec 31, 2024	170.88%
Sep 30, 2024	9.60%
Jun 30, 2024	72.00%
Mar 31, 2024	-0.92%
Dec 31, 2023	-38.36%
Sep 30, 2023	0.65%
Jun 30, 2023	10.82%
Mar 31, 2023	10.93%
Dec 31, 2022	77.45%
Sep 30, 2022	2.35%
Jun 30, 2022	2.18%
Mar 31, 2022	-18.00%
Dec 31, 2021	8.31%
Sep 30, 2021	7.70%
Jun 30, 2021	1.85%